Lower Extremity Complications in Adults With Type 2 Diabetes Treated With Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas: An Emulated Target Trial. uri icon

authors

  • McCoy, Rozalina G
  • Mickelson, Mindy M
  • Herrin, Jeph
  • Swarna, Kavya Sindhu
  • Polley, Eric C
  • Deng, Yihong
  • Chawla, Sagar
  • Neumiller, Joshua J
  • Galindo, Rodolfo J
  • Umpierrez, Guillermo E
  • Joseph S. Ross, MD, MHS

publication date

  • February 2, 2026